Number of items: 15.
2013
Mueller, M.,
Blunk, Torsten,
Appel, Bernhard,
Maschke, Angelika,
Goepferich, Achim and
Zellner, J.
(2013)
Insulin is essential for in vitro chondrogenesis of mesenchymal progenitor cells and influences chondrogenesis in a dose-dependent manner.
International orthopaedics 37 (1), pp. 153-158.
Fulltext not available.
2009
Appel, Bernhard,
Baumer, Julia,
Eyrich, Daniela,
Sarhan, Hatem,
Taso, S.,
Englert, Carsten and
Göpferich, Achim
(2009)
Synergistic effects of growth and differentiation factor-5 (GDF-5) and insulin on expanded chondrocytes in a 3-D environment.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 17 (11), pp. 1503-1512.
Fulltext not available.
2007
Eyrich, Daniela,
Wiese, H.,
Maier, G.,
Skodacek, Daniel,
Appel, Bernhard,
Sarhan, Hatem,
Teßmar, Jörg,
Staudenmeier, R.,
Wenzel, M. M.,
Göpferich, Achim and
Blunk, Torsten
(2007)
In Vitro and In Vivo Cartilage Engineering Using a Combination of Chondrocyte-Seeded Long-Term Stable Fibrin Gels and Polycaprolactone-Based Polyureth.
Tissue Engineering 13 (9), pp. 2207-2218.
Fulltext not available.
Eyrich, Daniela,
Brandl, Ferdinand,
Appel, Bernhard,
Wiese, H.,
Maier, G.,
Wenzel, M.,
Staudenmaier, R.,
Göpferich, Achim and
Blunk, Torsten
(2007)
Long-term stable fibrin gels for cartilage engineering.
Biomaterials 28 (1), pp. 55-65.
Fulltext not available.
2006
Appel, Bernhard,
Maschke, Angelika,
Weiser, Barbara,
Sarhan, Hatem,
Englert, Carsten,
Angele, Peter,
Blunk, Torsten and
Göpferich, Achim
(2006)
Lipidic implants for controlled release of bioactive insulin: Effects on cartilage engineered in vitro.
Int.J.Pharm. 314 (2), pp. 170-178.
Fulltext not available.
Maschke, Angelika,
Cali, N.,
Appel, Bernhard,
Kiermaier, J.,
Blunk, Torsten and
Göpferich, Achim
(2006)
Micronization of Insulin by High Pressure Homogenization.
Pharm.Res. 23 (9), pp. 2220-2229.
Fulltext not available.
2005
2004
Sarhan, Hatem,
Appel, Bernhard,
Eyrich, Daniela,
Göpferich, Achim and
Blunk, Torsten
(2004)
Effect of interleukin-4 on engineered cartilage in 3D cell culture.
In: International Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Nuremberg, Germany.
Fulltext not available.
Sarhan, Hatem,
Appel, Bernhard,
Eyrich, Daniela,
Göpferich, Achim and
Blunk, Torsten
(2004)
Effects of interleukin-4 on glycosaminoglycan content and matrix metalloproteinase expression in engineered cartilage.
In: Joint Meeting of the Tissue Engineering Society International (TESI) and the European Tissue Enginee, Lausanne, Switzerland.
Fulltext not available.
Maschke, Angelika,
Lucke, A.,
Vogelhuber, W.,
Fischbach, Claudia,
Appel, Bernhard,
Blunk, Torsten and
Göpferich, Achim
(2004)
Lipids: An alternative material for protein and peptide release.
In:
Svenson, Sönke, (ed.)
ACS Symposium Series 879.
, pp. 176-196.
Fulltext not available.
2003
Blunk, Torsten,
Sieminski, A. L.,
Appel, Bernhard,
Croft, C.,
Courter, D. L.,
Chieh, J. J.,
Göpferich, Achim and
Khurana, J. S.
(2003)
Bone morphogenetic protein 9: a potent modulator of cartilage development in vitro.
Growth Factors 21 (2), pp. 71-77.
Fulltext not available.
2002
Appel, Bernhard,
Maschke, Angelika,
Guse, C.,
Sarhan, Hatem,
Kellner, K.,
Blunk, Torsten and
Göpferich, Achim
(2002)
3-D cartilage engineering culture as a test system for growth factor application devices.
In: GZG Jahrestagung, Regensburg.
Fulltext not available.
Appel, Bernhard,
Maschke, Angelika,
Guse, C.,
Sarhan, Hatem,
Kellner, K.,
Blunk, Torsten and
Göpferich, Achim
(2002)
Lipid matrices release bioactive insulin in a 3-D cartilage engineering culture.
In: CRS Annual Meeting, Wien.
Fulltext not available.
This list was generated on Fri Dec 1 00:28:05 2023 CET.